Cytotoxic Effect of 4-Hydroxyisoleucine on Liver Cancer Cell Line
Background and Objectives: 4-hydroxyisoleucine is an amino acid in Fenugreek, which has antidiabetic properties. This effect is possibly brought about by activation of PI3K. In this study, cytotoxic effect of 4-hydroxyisoleucine on hepatoma cell lines was studied. Methods: In this experimental stu...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Qom University of Medical Sciences
2015-04-01
|
Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum |
Online Access: | http://journal.muq.ac.ir/article-1-200-en.html |
Summary: | Background and Objectives: 4-hydroxyisoleucine is an amino acid in Fenugreek, which has antidiabetic properties. This effect is possibly brought about by activation of PI3K. In this study, cytotoxic effect of 4-hydroxyisoleucine on hepatoma cell lines was studied. Methods: In this experimental study, HepG2 and Huh-7 cell lines were cultured in a 96-well microplate and after 24 hours incubation, cells were exposed to different concentrations of 4-hydroxyisoleucine (0.5-64mM). Cell viability was determined using MTT assay after 24, 48, and 72 hours of incubation. The results were analyzed using one-way ANOVA and Tukey’s test. Results: The percentage of cytotoxicity caused by 4-hydroxyisoleucine is concentration- and time-dependent. In this study, this difference was statistically significant compared to the control group (p<0.05), so that at the highest concentration (64mM) and after 72 hours, 65% and 61% of cell death was seen in HepG2 and Huh-7, respectively. IC 50 after 72 hours of incubation (at concentrations of 24mM and 23mM) was calculated for HepG2 and Huh-7, respectively. Conclusion: The results of this study showed that 4-hydroxyisoleucine not only does not cause cancer cell growth, but also has cytotoxic effects on hepatoma cell lines. Given the antidiabetic effect of 4-hydroxyisoleucine, it could be an appropriate candidate as an antidiabetic drug. |
---|---|
ISSN: | 1735-7799 2008-1375 |